세계의 동공측정계 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2028년)
Pupillometer - Market Insights, Competitive Landscape and Market Forecast-2028
세계의 동공측정계 시장 규모는 2022년 3억 5,171만 달러에서 2028년까지 5억 2,944만 달러에 달하며, 2023-2028년의 예측 기간 중 CAGR로 7.14%의 성장이 예측됩니다. 주로 뇌손상, 뇌종양, 뇌졸중, 호너 증후군 등의 신경질환 및 다양한 안과 질환의 증례 증가에 의해 전 세계에서 동공측정계의 수요가 촉진되고 있습니다.
세계의 동공측정계 시장에 대해 조사분석했으며, 시장 규모와 예측, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.
“The Pupillometer Market By Modality (Portable And Non-Portable), Application (Ophthalmology, Neurology, And Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), and geography ” is expected to grow at a steady CAGR forecast till 2028 owing to the rising prevalence of various neurological ophthalmic diseases and the increasing awareness associated with pupillometers and it's use across the globe
The global pupillometer market was valued at USD 351.71 million in 2022, growing at a CAGR of 7.14% during the forecast period from 2023 to 2028 to reach USD 529.44 million by 2028. The demand for pupillometers is primarily being boosted due to the increasing cases of neurological disorders such as brain injury, brain tumor, stroke, horner's syndrome, and others, and various ophthalmic disorders, globally. Further, the rising adoption of advanced and innovative technologies, the rising number of intensive care units, the frequent launches and approvals of advanced products, and others are thereby contributing to the overall growth of the pupillometer market during the forecast period from 2023-2028.
Pupillometer Market Dynamics:
The pupillometer market is witnessing a positive growth in product demand owing to various factors such as an increase in the prevalence of various neurology or ophthalmic disorders like traumatic brain injury, glaucoma, and others.
According to the Centers for Disease Control and Prevention (CDC) April 2023, there were approximately 69,473 traumatic brain injury (TBI) related hospitalizations in 2021, in the US. Severe brain injuries often result in abnormal pupil size and reactivity which are controlled by the autonomic nervous system, which can get malfunctioned during traumatic brain injuries. The other condition such as anisocoric, a condition where the pupils are unequal in size and increased intracranial pressure (ICP), which can be a result of brain swelling or bleeding or both are also associated with brain injury in which the use of pupillometry is required for measuring abnormal pupil size and reactivity.
Thus, pupillometry can be used as a diagnostic tool in assessing brain injury and monitoring the progress of patients, as it can also help in determining the severity of a brain injury. Henceforth, the increasing cases of traumatic brain injury may increase the demand during the forecast period.
Furthermore, the increasing cases of glaucoma, a progressive eye disease causing optic nerve damage, can increase the demand for pupilometers. For instance, according to CDC 2022, glaucoma is one of the leading causes of irreversible blindness in the United States. The source stated that by 2050, cases of glaucoma are expected to reach 6.3 million, in the US. Currently, there is no cure for glaucoma. But if the disease is found early, it can be treated and managed before vision loss or blindness occurs.
As there are usually no symptoms, only 50% of people with glaucoma even know they have it. The pupillometry can aid in the early detection and monitoring of glaucoma, allowing for timely intervention. It provides objective measurements of pupillary responses, helping assess disease severity and evaluate treatment effectiveness. Therefore, the increasing cases of glaucoma may need to use pupillometry for early diagnosis and timely intervention. Thus, the increasing cases of glaucoma may increase the demand for pupillometry devices in the upcoming years.
Thereby, the aforementioned factors will propel the overall market growth of pupillometer during the forecast period from 2023-2028.
However, the presence of alternative devices among others may restrict the pupillometer market growth.
Pupillometer Market Segment Analysis:
Pupillometer Market by Modality (Portable and Non-Portable), Application (Ophthalmology, Neurology, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the modality segment of the pupillometer, the portable device is expected to grow during the forecast period. This can be ascribed to the advantages offered by portable pupillometry.
Portable pupillometry is utilized in surgery for several purposes and indications as it helps in monitoring anesthesia depth, ensuring appropriate levels of sedation during any surgical procedure, and detecting any intraoperative complications that may affect pupil function. Pupillometry also allows for the evaluation of immediate postoperative outcomes and the identification of any changes in pupil function that may require further investigation or intervention.
Portable pupillometry is s a convenient tool for anesthesia providers and surgical teams to assess pupil responses and make immediate adjustments during the procedure, especially in situations where non-portable devices are not readily available, such as during inpatient surgery.
For instance, according to the World Health Organization (WHO) 2022, nearly 8,529,608 cases of total inpatient surgery were done in Russia in 2021. In such cases, a pupilometer can be used to monitor different parameters such as anesthesia depth, sedation levels, hemorrhagic stroke, and cerebral edema, among others. Therefore, the rising utilization of portable pupillometry during surgeries for evaluating postoperative outcomes will increase its demand in the market.
Also, portable pupillometry devices offer the advantage of mobility and ease of use in various settings, including the operating room. Portable devices are smaller, handheld, and often more accessible, allowing for real-time pupil measurements during surgery. Overall, the demand for potable pupillometry devices in surgical settings is driven positively for enhanced patient safety, improved outcomes, and others.
Thus, the above-mentioned factors and the advantages offered by portable devices over others are predicted to contribute to the increasing demand for this segment type, thereby propelling the overall market of pupillometers during the upcoming years.
North America is expected to dominate the overall Pupillometer Market:
Among all the regions, North America is estimated to account for the largest share of the pupillometer market in the year 2022. Owing to the significance of key growth factors such as the increasing cases of brain tumors, stroke, glaucoma, retinal, cerebral vascular disease, amblyopia, and others are thereby driving the North American pupillometer market in the forthcoming years. Furthermore, the increasing old age population prone to neurological or ophthalmic diseases, the high disposable income, the sophisticated healthcare infrastructure, the rising number of working hours, the high awareness about eye diagnosis, and others will also help the market growth in this region.
Brain tumors can affect pupillometry by exerting pressure on cranial nerves, leading to changes in pupil size and reactivity. Tumors located near the brainstem or base of the skull can compress the cranial nerves responsible for controlling the pupils, resulting in dilation or constriction of the pupil. Additionally, brain tumors can increase intracranial pressure, causing pupil dilation or sluggish response. Brain tumors can also disrupt the autonomic nervous system, which regulates pupil function.
For instance, according to the National Brain Tumor Society (2023), estimated that 94,390 Americans will receive a primary brain tumor diagnosis in 2023, in the US. However, as the population increases, the overall number of individuals at risk for developing brain tumors may also rise. Pupillometry is used alongside other diagnostic methods to assess the impact of brain tumors on neurological function. Thus, the increasing cases of brain tumors may also increase the demand for pupillometry devices in a region.
Furthermore, a stroke occurs when the blood supply to the brain is disrupted, leading to damage in that area. This can affect the nerves that control the pupils, the black circular openings in the eyes. As a result, a stroke can cause changes in pupil size or reactivity. These changes may include unequal pupil sizes (anisocoria), constricted pupils (miosis), dilated pupils (mydriasis), or sluggish/non-reactive pupils. For instance, according to CDC 2023, every 40 seconds, someone in the United States has a stroke. Every year, more than 795,000 people in the United States have a stroke. About 610,000 of these are first or new strokes and about 185,000 strokes, nearly 1 in 4 are in people who have had a previous stroke. Therefore, pupilometry provides objective and quantitative data that can aid in the early detection of complications and assist in assessing the progression of complications related to stroke.
Pupilometry plays a crucial role in the comprehensive evaluation and care of stroke patients, contributing to better outcomes and more targeted treatment approaches. Thus, the increasing number of cases of stroke in the region may increase the demand for pupilometry.
Therefore, the aforementioned factors would provide a positive growth environment for the North American region in the pupillometer device market.
Pupillometer Market Key Players:
Some of the key market players operating in the pupillometer market include NeurOptics, Inc., IDMED, Essilor Instruments USA, Reichert, Inc., Gulden Ophthalmics, iVIS Technologies, NIDEK CO., LTD., AddVision Sweden, Adaptica, Johnson & Johnson Vision, Alcon Vision LLC, Chongqing Yeasn Science & Technology Co. Ltd, BioMedix Optotechnik & Devices Pvt. Ltd., Mediworks, Visionix, Takagi Seiko Co., LTD., and others.
Recent Developmental Activities in the Pupillometer Market:
Key Takeaways from the Pupillometer Market Report Study
Target Audience who can be benefited from this Pupillometer Market Report Study
Frequently Asked Questions for the Pupillometer Market: